McLellan, F <br/><br/>
US FDA weighs options for warning on antihypertensive drug.  [electronic resource] 

 -  Lancet (London, England)  Jun 2001 
 - 1775 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(00)04948-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antihypertensive Agents--adverse effects<br/>Doxazosin--adverse effects<br/>Drug Labeling<br/>Heart Failure--chemically induced<br/>Humans<br/>United States<br/>United States Food and Drug Administration